Literature DB >> 28350091

Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.

Tomonari Asano1, Suguru Yamada1, Bryan C Fuchs2, Hideki Takami1, Masamichi Hayashi1, Hiroyuki Sugimoto1, Tsutomu Fujii1, Kenneth K Tanabe2, Yasuhiro Kodera1.   

Abstract

The epithelial-to-mesenchymal transition (EMT) is an initial, critical step in hepatocellular carcinoma (HCC) tumor invasion and metastasis. Frizzled 2 (Fzd2) expression might drive EMT through the non-canonical Wnt pathway, one of the various EMT signaling pathways. The expression of epithelial (E-cadherin) and mesenchymal (vimentin) markers, as well as that of Wnt5b, Stat3, IL-6, Jak2 and Fzd2, were measured in 15 HCC cell lines. The EMT status (vimentin to E-cadherin mRNA expression ratio), Fzd2 mRNA expression, and pSTAT3 protein expression were assessed by immunostaining in 100 HCC patients, and correlations of their expression with clinicopathological factors and prognosis were analyzed. Cell proliferation, migration, and invasiveness were assessed after Fzd2 knockdown. Fzd2 expression was significantly correlated with a mesenchymal phenotype in the HCC cell lines. Treatment of the cell lines with Fzd2 siRNA resulted in significantly reduced migration and invasiveness but did not affect proliferation. A significant correlation was detected between the EMT status and Fzd2 expression in the HCC patients. Multivariate analysis revealed that Fzd2 expression was an independent predictor of recurrence (P=0.034). Patients with high Fzd2 expression had significantly poorer recurrence‑free survival than those with low expression (P=0.03). Finally, pSTAT3 expression was significantly correlated with the EMT and Fzd2 status (P=0.0028, and P=0.0066, respectively). Fzd2 expression induced EMT and enhanced cell migration and invasiveness, and it might be a novel predictor of HCC recurrence. Furthermore, Stat3 might be controlled by both the Wnt5/Fzd2 and IL-6/Jak2 signaling pathways and play an important role in EMT.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28350091     DOI: 10.3892/ijo.2017.3937

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.

Authors:  Shu Ning; Chengfei Liu; Wei Lou; Joy C Yang; Alan P Lombard; Leandro S D'Abronzo; Neelu Batra; Ai-Ming Yu; Amy R Leslie; Masuda Sharifi; Christopher P Evans; Allen C Gao
Journal:  Mol Cancer Ther       Date:  2022-10-07       Impact factor: 6.009

Review 2.  Deregulation of Frizzled Receptors in Hepatocellular Carcinoma.

Authors:  Kristy Kwan-Shuen Chan; Regina Cheuk-Lam Lo
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

3.  Caveolin-1 down-regulation is required for Wnt5a-Frizzled 2 signalling in Ha-RasV12 -induced cell transformation.

Authors:  Hsiu-Kuan Lin; Hsi-Hui Lin; Yu-Wei Chiou; Ching-Lung Wu; Wen-Tai Chiu; Ming-Jer Tang
Journal:  J Cell Mol Med       Date:  2018-03-04       Impact factor: 5.310

4.  Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.

Authors:  Huohui Ou; Zhanjun Chen; Leyang Xiang; Yinghao Fang; Yuyan Xu; Qin Liu; Zhigang Hu; Xianghong Li; Yu Huang; Dinghua Yang
Journal:  Cancer Sci       Date:  2019-03-06       Impact factor: 6.716

5.  FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma.

Authors:  Li Huang; Er-Ling Luo; Jing Xie; Rui-Huan Gan; Lin-Can Ding; Bo-Hua Su; Yong Zhao; Li-Song Lin; Da-Li Zheng; You-Guang Lu
Journal:  Int J Biol Sci       Date:  2019-08-24       Impact factor: 6.580

Review 6.  Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside.

Authors:  Gabriel Siracusano; Mariella Tagliamonte; Luigi Buonaguro; Lucia Lopalco
Journal:  Vaccines (Basel)       Date:  2020-01-24

7.  A comprehensive characterization of the transcriptome in enzalutamide resistance prostate cancer.

Authors:  Lili Wang; Yun Peng; Shiqiang Dong; Dingkun Hou; Nan Li; Hongzheng Li; Tianyang Li; Zheyu Zhang; Haitao Wang
Journal:  Ann Transl Med       Date:  2021-12

Review 8.  Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Authors:  Michaël H Meel; Sophie A Schaper; Gertjan J L Kaspers; Esther Hulleman
Journal:  Cell Mol Life Sci       Date:  2017-11-21       Impact factor: 9.261

9.  Analysis of the role of Frizzled 2 in different cancer types.

Authors:  Miaomiao Zhou; Xuezhu Sun; Yunhao Zhu
Journal:  FEBS Open Bio       Date:  2021-02-25       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.